References
- Reingold AL, Hargrett NT, Dan BB, Shands K, Strickland B, Broome C. Non-menstrual toxic shock syndrome. A review of 130 cases. Ann Intern Med 1982; 96: 871–4
- Martinello R, Cooney E. Cerebellar brain abscess associated with tongue piercing. Clin Infect Dis 2003; 36: 32–4
- Friedel J, Stehlik J, Desai M, Granato J. Infective endocarditis after oral body piercing. Cardiol Rev 2003; 11: 252–5
- Ekelius L, Bjorkman H, Kalin M, Fohlman J. Fournier's gangrene after genital piercing. Scand J Infect Dis 2004; 36: 610–22
- Shulman B. Ear piercing and sepsis. Clin Pediatr (Phila.) 1973; 12: 27A
- Tweeten SS, Rickman LS. Infectious complications of body piercing. Clin Infect Dis. 1998; 26: 735–40
- McCarthy VP, Peoples WM. Toxic shock syndrome after ear piercing. Pediatr Infect Dis J 1988; 7: 741–2
- Stevens DL, Tanner MH, Winship J, Swarts R, Ries KM, Schlievert PM, Kaplan E. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 1989; 321: 1–7
- Kain KC, Schulzer M, Chow AW. Clinical spectrum of non-menstrual toxic shock syndrome (TSS): comparison with menstrual TSS by multivariate discriminate analyses. Clin Infect Dis 1993; 16: 100–6
- Schlievert P, Shands K, Dan B, Schmid G, Nishimura R. Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome. J Infect Dis 1981; 143: 509–16
- Schlievert P. Role of superantigens in human disease. J Infect Dis 1993; 167: 997–1002
- De Boer M, Kum W, Pang L, Chaw A. Co-production of staphylococcal enterotoxin A with toxic shock syndrome toxin-1 (TSST-1) enhances TSST-1 mediated mortality in a D-galactosamine sensitized mouse model of lethal shock. Microb Pathog 1999; 27: 61–70
- Jarraud S, Cozon G, Vandenesch F, Bes M, Etienne J, Lina G. Involvement of enterotoxin G and I in staphylococcal toxic shock syndrome and staphylococcal scarlet fever. J Clin Microbiol 1999; 37: 2446–9
- Garbe P, Arko R, Reingold A, Graves L, Hayes P, Hightower A, et al. Staphylococcus aureus isolated from patients with non-menstrual toxic shock syndrome. Evidence for additional toxins. JAMA 1985; 253: 2538–42
- Stevens D, Wallace R, Hamilton S, Bryant A. Successful treatment of staphylococcal toxic shock syndrome with linezolid: a case report and in vitro evaluation of the production of toxic shock syndrome toxin type 1 in the presence of antibiotics. Clin Infect Dis 2006; 42: 729–30
- Bohach G, Fast D, Nelson R, Schlievert P. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Clin Rev Microbiol 1990; 17: 251–72